55 news items
DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
QDEL
11 Jun 24
to customers than they could sell to consumers and healthcare providers. The Company suffered from excess inventories throughout the supply chain. Based
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
QDEL
10 Jun 24
) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (2
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
QDEL
10 Jun 24
sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (2
DEADLINE ALERT for SOND, OCGN, VFS, and QDEL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
OCGN
QDEL
SOND
10 Jun 24
to healthcare providers and end customers; (2) that excess inventories of COVID-19 tests existed throughout the supply chain; (3) that, as a result
QUIDELORTHO CORPORATION (NASDAQ: QDEL) FINAL DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline
QDEL
10 Jun 24
to investors that: (a) QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare
oxnlxzx7nb39i4gunm o3hhhf65tjiqszv
QDEL
10 Jun 24
to customers than they could sell to consumers and healthcare providers. The Company suffered from excess inventories throughout the supply chain. Based
k2zbf1mms6o3kqymg5idsjk mhyzpeg1rz0xynxc5u2s3ra949i4pgdv5
QDEL
10 Jun 24
resell to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed throughout the supply chain; (c
42yqk7k1ntf2bnfo1tuqf0keth6x6bhlmzlyozkfy5qr9fyf9bnf7ik
QDEL
10 Jun 24
tests to government customers, healthcare providers (through its authorized distributors), and large retail pharmacy chains. QuidelOrtho manufactures
572orbnin
QDEL
9 Jun 24
resell to healthcare providers and end customers; (2) excess inventories of COVID-19 tests existed throughout the supply chain; (3) as a result
ul15qo0dfdykzp5cupck85l7oz7
QDEL
8 Jun 24
and pharmacy chain customers than they could resell to healthcare providers and end customers; (2) excess inventories of COVID-19 tests existed throughout
872c 3yuqmn
QDEL
8 Jun 24
, and prospects: (1) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers
j6rlm5huc06pvxpqw8jaf5xnjbs b7xl75
OCGN
PERI
QDEL
7 Jun 24
customers, healthcare providers (through its authorized distributors), and large retail pharmacy chains. QuidelOrtho manufactures respiratory tests under
3avwamu dec59k2zg8qzo51ny28zj
QDEL
7 Jun 24
resell to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed throughout the supply chain; (c
g3yvj0y7gh8rnz9jkimzw6cm1t50xrsu824dhaoybog0fod8ua
QDEL
7 Jun 24
. QuidelOrtho sold more COVID-19 test kits to customers than they could sell to consumers and healthcare providers. The Company suffered from excess
jj6uy5tbiixfnt74j16t6ng th3xwbzc5hj78haf
QDEL
6 Jun 24
resell to healthcare providers and end customers; (2) excess inventories of COVID-19 tests existed throughout the supply chain; (3) as a result
5y1y0wzzx0f w3rkhnmiq4zk
QDEL
6 Jun 24
) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (2
gtkr4zkpnw sr7g
QDEL
6 Jun 24
and pharmacy chain customers than they could resell to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed
wt80qdchikx3ut 3q
QDEL
6 Jun 24
. QuidelOrtho sold more COVID-19 test kits to customers than they could sell to consumers and healthcare providers. The Company suffered from excess
8i57xnx5z1bprf1opcwnfb6rflbwhq bvdvyh9gh3uuz20syyrkynqz0x
QDEL
6 Jun 24
: (1) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end
8eltnax 98tiyiuwet8hf3xcoynny3l14
QDEL
6 Jun 24
to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed throughout the supply chain; (c) that, as a result